O'Shaughnessy Asset Management, LLC Harvard Bioscience Inc Transaction History

O'Shaughnessy Asset Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$4.02 - $5.39 $8,048 - $10,790	-2,002 Reduced 11.44%	15,502 $65,000
Q4 2023 Feb 09, 2024	SELL	$4.0 - $5.49 $12,520 - $17,183	-3,130 Reduced 15.17%	17,504 $93,000
Q3 2023 Nov 13, 2023	BUY	$4.0 - $5.82 $6,108 - $8,887	1,527 Added 7.99%	20,634 $88,000
Q2 2023 Aug 11, 2023	BUY	$4.19 - $6.16 $80,058 - $117,699	19,107 New	19,107 $104,000
Q4 2021 Feb 11, 2022	SELL	$6.37 - $8.18 $2,248 - $2,887	-353 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$6.98 - $8.47 $991 - $1,202	142 Added 67.3%	353 $2,000
Q2 2021 Aug 09, 2021	BUY	$5.44 - $8.4 $1,147 - $1,772	211 New	211 $2,000
Q1 2019 May 10, 2019	SELL	$2.77 - $4.38 $13,811 - $21,838	-4,986 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$3.03 - $5.0 $13,956 - $23,030	-4,606 Reduced 48.02%	4,986 $16,000
Q2 2018 Aug 10, 2018	SELL	$4.2 - $5.95 $2,242 - $3,177	-534 Reduced 5.27%	9,592 $51,000
Q1 2018 May 08, 2018	BUY	$3.3 - $5.15 $33,415 - $52,148	10,126 New	10,126 $51,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.